Spry2 is a novel therapeutic target for periodontal tissue regeneration through fibroblast growth factor receptor signaling and epidermal growth factor signaling
2005 ◽
Vol 170
(4)
◽
pp. 559-570
◽
2002 ◽
Vol 277
(23)
◽
pp. 20618-20624
◽
1997 ◽
Vol 27
(3)
◽
pp. 647
2000 ◽
Vol 30
(3)
◽
pp. 505
2008 ◽
Vol 318
(2)
◽
pp. 276-288
◽